BRCA1 interacts with components of the histone deacetylase complex - PubMed (original) (raw)
BRCA1 interacts with components of the histone deacetylase complex
R I Yarden et al. Proc Natl Acad Sci U S A. 1999.
Abstract
Germ-line mutations in the BRCA1 tumor-suppressor gene are associated with an increased susceptibility to breast and ovarian cancer. BRCA1 contains a carboxyl-terminal domain (BRCT) that is shared with several other proteins involved in maintaining genome integrity. In an effort to understand the function of BRCA1, we sought to isolate proteins that interact with the BRCT domain. Purified BRCT polypeptide was used as a probe to screen a human placenta cDNA expression library by Far Western analysis. Here we report that BRCA1 interacts in vivo and in vitro with the Rb-binding proteins, RbAp46 and RbAp48, as well as with Rb. Moreover, the BRCT domain associates with the histone deacetylases HDAC1 and HDAC2. These results demonstrate that BRCA1 interacts with components of the histone deacetylase complex, and therefore may explain the involvement of BRCA1 in multiple processes such as transcription, DNA repair, and recombination.
Figures
Figure 1
The BRCT domain binds to Rb-binding proteins in vitro. (A) Schematic representation of BRCA1 gene. The region used as a probe in the library screen is indicated. (B) GST pull-down assays demonstrating that BRCT domain interacts with partial polypeptide of RbAp46 and full-length RbAp46 and RbAp48 proteins. _In vitro_-translated, 35S-labeled BRCT (10 μl) was incubated with 20 μl of glutathione-Sepharose beads and an equal amount of GST or GST-fusion proteins, as indicated. After extensive washing, bound proteins were eluted, resolved on SDS/10% PAGE, and visualized by using autoradiography. A portion of the _in vitro_-translated, 35S-labeled BRCT, corresponding to ≈20% of the labeled protein in the binding reaction, was loaded as “Input”. (C) Schematic representation of the BRCT repeats. Mutations analyzed for in vitro binding are indicated. (D) Mutations in BRCT domain interfere with interaction between RbAp46 and BRCT. GST pull-down assays were performed as in A with the wild type or mutation-containing BRCT polypeptides as indicated. Approximately 5% of each _in vitro_-translated protein in the binding reactions were loaded as Input.
Figure 2
In vivo association of BRCA1 with Rb-binding proteins. (A) Coimmunoprecipitation of BRCA1 and RbAp46/48. Endogenous BRCA1 protein was immunoprecipitated by anti-BRCA1 mAb SG11 (lane 2), anti-RbAp46/48 mAbs: RbBp (lane 3); RbAp48–3-255 (lane 4) and controls: normal mouse IgG (NMIgG, lane 1) and anti-c-jun mAb KM-1 (lane 5) from 1.5 mg of HeLa cell extract. Total cell lysate (100 μg) was run in lane 6. Protein extract (1.5 mg) from the BRCA1-null cell line, HCC1937 (42), were immunoprecipitated with anti-BRCA1 mAb SG11 (lane 7). Samples were separated on SDS/6% PAGE and immunoblotted with the mAb anti-BRCA1 antibody (Ab-1, Oncogene Science). (B) Colocalization of BRCA1 and RbAp46/48 in HeLa cells. Cells were prepared as described in Materials and Methods, stained with a mouse mAb against RbAp48/46, 3–225, (green in a), a rabbit polyclonal Ab against BRCA1, I-20, (red in b), and visualized by using microscope and charge-coupled device camera. The regions of overlap between red and green signals appear as yellow (c), indicating colocalization of BRCA1 and RbAps. The nucleus of each cell are shown by 4′,6-diamidino-2-phenylindole (DAPI) staining (d). White arrowheads indicate some regions of overlap of BRCA1 and RbAps staining**.** (C) Colocalization of BRCA1 and RbAp46/48 in Saos2 cells. Cells were prepared as described in Materials and Methods and stained as in B.
Figure 3
Rb interacts with the BRCT domain. (A) GST pull-down experiments show that Rb interacts with BRCT domain in the presence or absence of partial RbAp46 polypeptide. _In vitro_-translated, 35S-labeled BRCT (12.5 μl) and partial RbAp46 polypeptides were incubated individually or in combination with 20 μl of glutathione-Sepharose beads with equal amount of GST-Rb or GST-Rb pocket mutation fusion proteins as indicated. GST-coated beads were incubated with each polypeptide separately. After extensive washing, bound proteins were eluted, resolved on SDS/10% PAGE and visualized by using autoradiography. Approximately 20% of labeled protein in the binding reaction were loaded as Input. (B) Colocalization of BRCA1 and Rb. HeLa cells were prepared as described in Material and Methods, stained with a mouse mAb against Rb, IF8, (green in a), a rabbit polyclonal antibody against BRCA1, I-20, (red in b). The regions of overlap between red and green signals appear as yellow (c), indicating colocalization of BRCA1 and Rb. The nucleus of each cells are shown by DAPI staining (d).
Figure 4
The BRCT domain associates with HDAC1 and HDAC2. Western blot analysis of GST pull-down assays using antibodies against HDAC1 and HDAC2. HeLa whole-cell lysates (300 μg) were incubated with 20 μl of glutathione-Sepharose beads covered with equal amounts of GST, GST-BRCT (amino acids 1,536–1,863), or GST-NH2-BRCA1 (amino acids 1–304) fusion proteins. Bound proteins were resolved on SDS/10% PAGE, transferred to nitrocellulose membranes, and blotted with HDAC1 or HDAC2 Abs.
Similar articles
- The histone deacetylase HDAC3 targets RbAp48 to the retinoblastoma protein.
Nicolas E, Ait-Si-Ali S, Trouche D. Nicolas E, et al. Nucleic Acids Res. 2001 Aug 1;29(15):3131-6. doi: 10.1093/nar/29.15.3131. Nucleic Acids Res. 2001. PMID: 11470869 Free PMC article. - Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1.
Chen GC, Guan LS, Yu JH, Li GC, Choi Kim HR, Wang ZY. Chen GC, et al. Biochem Biophys Res Commun. 2001 Jun 8;284(2):507-14. doi: 10.1006/bbrc.2001.5003. Biochem Biophys Res Commun. 2001. PMID: 11394910 - Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.
Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. Zhang Y, et al. Genes Dev. 1999 Aug 1;13(15):1924-35. doi: 10.1101/gad.13.15.1924. Genes Dev. 1999. PMID: 10444591 Free PMC article. - Interactions between BRCT repeats and phosphoproteins: tangled up in two.
Glover JN, Williams RS, Lee MS. Glover JN, et al. Trends Biochem Sci. 2004 Nov;29(11):579-85. doi: 10.1016/j.tibs.2004.09.010. Trends Biochem Sci. 2004. PMID: 15501676 Review. - BRCT domains: phosphopeptide binding and signaling modules.
Rodriguez MC, Songyang Z. Rodriguez MC, et al. Front Biosci. 2008 May 1;13:5905-15. doi: 10.2741/3125. Front Biosci. 2008. PMID: 18508631 Review.
Cited by
- Expression analysis and mapping of Viral-Host Protein interactions of Poxviridae suggests a lead candidate molecule targeting Mpox.
Loganathan T, Fletcher J, Abraham P, Kannangai R, Chakraborty C, El Allali A, Alsamman AM, Zayed H, C GPD. Loganathan T, et al. BMC Infect Dis. 2024 May 10;24(1):483. doi: 10.1186/s12879-024-09332-x. BMC Infect Dis. 2024. PMID: 38730352 Free PMC article. - Interpreting the molecular mechanisms of RBBP4/7 and their roles in human diseases (Review).
Zhan Y, Yin A, Su X, Tang N, Zhang Z, Chen Y, Wang W, Wang J. Zhan Y, et al. Int J Mol Med. 2024 May;53(5):48. doi: 10.3892/ijmm.2024.5372. Epub 2024 Apr 5. Int J Mol Med. 2024. PMID: 38577935 Free PMC article. Review. - Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA.
Szczepanek J, Skorupa M, Jarkiewicz-Tretyn J, Cybulski C, Tretyn A. Szczepanek J, et al. Int J Mol Sci. 2023 Apr 13;24(8):7235. doi: 10.3390/ijms24087235. Int J Mol Sci. 2023. PMID: 37108398 Free PMC article. Review. - The repair gene BACH1 - a potential oncogene.
Muhseena N K, Mathukkada S, Das SP, Laha S. Muhseena N K, et al. Oncol Rev. 2021 Jul 2;15(1):519. doi: 10.4081/oncol.2021.519. eCollection 2021 Feb 26. Oncol Rev. 2021. PMID: 34322202 Free PMC article.
References
- Futreal P A, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett L M, Haugen-Strano A, Swensen J, Miki Y, et al. Science. 1994;266:120–122. - PubMed
- Merajver SD, Pham T M, Caduff R F, Chen M, Poy E L, Cooney K A, Weber B L, Collins F S, Johnston C, Frank T S. Nat Genet. 1995;9:439–443. - PubMed
- Langston A A, Malone K E, Thompson J D, Daling J R, Ostrander E A. N Engl J Med. 1996;334:137–142. - PubMed
- Castilla L H, Couch F J, Erdos M R, Hoskins K F, Calzone K, Garber J E, Boyd J, Lubin M B, Deshano M L, Brody L C, et al. Nat Genet. 1994;8:387–391. - PubMed
- Friedman L S, Ostermeyer E E, Szabo C I, Dowd P, Lynch E D, Rowell S E, King M-C. Nat Genet. 1994;8:399–404. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous